Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study

By G. Bedogni, L. Miglioli, F. Masutti, C. Tiribelli, Giulio Marchesini, S. Bellentani. Hepatology, 2005

1,331 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/62326fcdfab10a32af7bf7d34e5d36dfa3b5ec27

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

In Epidemiology

In Pathology and Forensic Medicine

Citations in the corpus

Epidemiology of Non-Alcoholic Fatty Liver Disease (2010, methodology): “It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , , , , , , , , , , , , ,”
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults (2011, background): “showed that the prevalence of NAFLD in Italian subjects with and without suspected liver disease was 25% and 20%, respectively.(12) In addition, over 10 to 12 years, the”
Non-alcoholic fatty liver disease: the mist gradually clears. (2008, background): “With this proviso the prevalence of NAFLD appears to be around 20–30% in Western adults [1,2] and 15% in Asians [3].”
Human Intestinal Barrier Function in Health and Disease (2016, background): “drome involves a complex spectrum of pathological changes, including steatosis, nonalcoholic steatohepatitis, fibrosis, and cirrhosis.(107,108) Changes in TJ protein expression and distribution are suggested as critical factors in the impairment of gut barrier function and subsequent alterations in ”
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population (2006, methodology): “%) of them had suspected liver disease (SLD) according to at least one of the following criteria: 1) alanine transaminase (ALT) > 30 U*L-1; 2) gammaglutamyl-transferase (GGT) > 35 U*L-1; 3) presence of hepatitis B surface antigen (HBsAg); 4) presence of Hepatitis C (HCV) virus ribonucleic acid (RNA)”
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease (2018, background): “In the last two decades, it has become the most “emerging” liver disease worldwide, since we are moving towards a gradual reduction of viral hepatitis and a progressive increase of obesity, following the spread of a “western lifestyle” [2, 3].”
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD (2007, methodology): “Validation was performed (1) in the validation dataset (n 253) and (2) in the full dataset (n 733).”
Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation (2014, background): “As many as 30% of adults in Western countries have NAFLD and up to 12% of whom have NASH.(146,147) In those with NASH, progression to advanced fibrosis and cirrhosis occurs in 30% and 10%, respectively, over a 5-year period.”
A position statement on NAFLD/NASH based on the EASL 2009 special conference. (2010, background): “The prevalence of NAFLD in the general population assessed by ultrasonography is 20–30% in Europe [8,9] and the Middle East [10], 15% in the Far East [11,12], and 16% in some studies of normal weight subjects without metabolic risk factors [2].”